Market revenue in 2022 | USD 0.9 million |
Market revenue in 2030 | USD 3.3 million |
Growth rate | 16.9% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 55.56% in 2022. Horizon Databook has segmented the South Korea veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Genetic improvement programs have been established in the country to develop economic breeds of bovine, thereby supporting meat and milk production through artificial selection insemination techniques. The country's Dairy Cattle Improvement Center (DCIC) has been the sole artificial insemination center for distributing and producing cattle/bovine semen since 1962.
Such breeding activities have been used by local farmers to raise Hanwoo (native cattle breed) for years to expand their production rate. As per an article published in 2021 by the Journal of Animal Science and Technology, artificial insemination is commonly preferred in South Korea to breed Hanwoo cattle.
These factors are supporting the growth of the market. In addition, USDA reported that Korean cattle producers aimed to increase cattle slaughter rates in 2023.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into South Korea veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account